GENEVA – The Global Antibiotic Research and Development Partnership (GARDP) is pleased to announce £1 million investment from the Wellcome Trust. This funding will contribute … Wellcome Trust funds GARDP’s efforts to develop and deliver antibiotics for drug-resistant infections
हिन्दी GENEVA AND NEW DELHI – Over 80 researchers from 11 countries are meeting in New Delhi today to kick off an observational study to … Researchers gather in New Delhi to kick off observational study for newborns with sepsis
GENEVA AND LONDON – The Global Antibiotic Research and Development Partnership (GARDP) is pleased to announce a £1m investment from the UK Government’s Department of Health … GARDP’s efforts to address drug-resistant gonorrhoea treatment receive boost from UK government
GENEVA – The Global Antibiotic Research and Development Partnership (GARDP) is pleased to announce the strengthening of its collaborative efforts with the South African Medical … South African Medical Research Council funds GARDP efforts to deliver new antibiotics for drug-resistant infections
GENEVA – The Global Antibiotic Research and Development Partnership (GARDP) welcomes DRIVE-AB’s acknowledgement that a combination of ways to apply and attract financial investments in … GARDP welcomes DRIVE-AB’s report revitalizing the antibiotic pipeline
8 November 2017, Geneva – Non-profit research and development organization the Global Antibiotic Research and Development Partnership (GARDP) and the Drugs for Neglected Diseases initiative (DNDi) … GARDP and DNDi launch new South Africa liaison office, hosted by South African Medical Research Council
[Deutsch] BERLIN– Germany together with a number of countries and foundations today pledged EUR 56.5 million to help develop new treatments to fight against antibiotic … 56 million euros raised to fund initiative to fight antibiotic resistance
GENEVA AND BOSTON – Entasis and GARDP will co-develop the first-in-class antibiotic, zoliflodacin, in a global Phase III clinical trial to be carried out in … Entasis Therapeutics and the Global Antibiotic Research & Development Partnership to develop a new treatment for gonorrhea